Manufacturer of Controlled Substances; Notice of Registration, 24455 [05-9177]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 88 / Monday, May 9, 2005 / Notices
Information and Regulatory Affairs,
Attention Department of Justice Desk
Officer, Washington, DC 20503.
Additionally, comments may be
submitted to OMB via facsimile to (202)
395–5806. Written comments and
suggestions from the public and affected
agencies concerning the proposed
collection of information are
encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agencies
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Enhance the quality, utility, and
clarity of the information to be
collected; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
(1) Type of Information Collection:
Extension of a currently approved
collection.
(2) Title of the Form/Collection:
Firearms Transaction Record Low
Volume Part I Over-the-Counter and
Part II Intra-State Non-Over-the-Counter.
(3) Agency form number, if any, and
the applicable component of the
Department sponsoring the collection:
Form Number: ATF F 4473 (5300.24)
Part I (LV) and ATF F 4473 (5300.25)
Part II (LV) and ATF REC 7570/2.
Bureau of Alcohol, Tobacco, Firearms
and Explosives.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Primary: Business or other forprofit. Other: Individual or households.
The forms are used by low volume
firearms dealers to record acquisition
and disposition of firearms and to
determine the eligibility of buyers to
receive firearms. The forms are part of
the licensee’s permanent record and
may be used to trace firearms.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond/reply: It is estimated that 1,000
VerDate jul<14>2003
17:20 May 06, 2005
Jkt 205001
respondents will complete a 20-minute
form.
(6) An estimate of the total public
burden (in hours) associated with the
collection: There are an estimated 1,666
annual total burden hours associated
with this collection.
If additional information is required
contact: Brenda E. Dyer, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Patrick Henry Building,
Suite 1600, 601 D Street NW.,
Washington, DC 20530.
Dated: May 4, 2005.
Brenda E. Dyer,
Department Clearance Officer, Department of
Justice.
[FR Doc. 05–9181 Filed 5–6–05; 8:45 am]
BILLING CODE 4410–FY–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated June 28, 2004, and
published in the Federal Register on
July 13, 2004, (69 FR 42068), Eli-Elsohly
Laboratories, Inc., Mahmoud A. Elsohly
PhD., 5 Industrial Park Drive, Oxford,
Mississippi 38655, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
of controlled substances listed in
Schedule I and II:
Drug
Schedule
Tetrahydrocannabinols (7370) .....
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Morphine (9300) ...........................
I
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances for use
in analysis and drug test standards.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of EliElsohly Laboratories, Inc. to
manufacture the listed basic classes of
controlled substances is consistent with
the public interest at this time. DEA has
investigated Eli-Elsohly Laboratories,
Inc. to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
24455
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR
1301.33(a), the above named company is
granted registration as a bulk
manufacturer of the basic classes of
controlled substances listed.
Dated: May 2, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–9177 Filed 5–6–05; 8:45 am]
BILLING CODE 4410–09–P
NATIONAL FOUNDATION ON THE
ARTS AND THE HUMANITIES
Federal Council on the Arts and the
Humanities, Arts and Artifacts
Indemnity Panel Advisory Committee;
Notice of Meeting
Pursuant to the provisions of the
Federal Advisory Committee Act (Pub.
L. 92–463 as amended) notice is hereby
given that a meeting of the Arts and
Artifacts Indemnity Panel of the Federal
Council on the Arts and the Humanities
will be held at 1100 Pennsylvania
Avenue, NW., Washington, DC 20506,
in Room 714, from 9 a.m. to 5 p.m., on
Monday, May 23, 2005.
The purpose of the meeting is to
review applications for Certificates of
Indemnity submitted to the Federal
Council on the Arts and the Humanities
for exhibitions beginning after July 1,
2005.
Because the proposed meeting will
consider financial and commercial data
and because it is important to keep
values of objects, methods of
transportation and security measures
confidential, pursuant to the authority
granted me by the Chairman’s
Delegation of Authority to Close
Advisory Committee Meetings, dated
July 19, 1993, I have determined that the
meeting would fall within exemption (4)
of 5 U.S.C. 552(b) and that it is essential
to close the meeting to protect the free
exchange of views and to avoid
interference with the operations of the
Committee.
It is suggested that those desiring
more specific information contact
Acting Advisory Committee
Management Officer, Michael
McDonald, 1100 Pennsylvania Avenue,
E:\FR\FM\09MYN1.SGM
09MYN1
]]>Agencies
[Federal Register Volume 70, Number 88 (Monday, May 9, 2005)]
[Notices]
[Page 24455]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-9177]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated June 28, 2004, and published in the Federal
Register on July 13, 2004, (69 FR 42068), Eli-Elsohly Laboratories,
Inc., Mahmoud A. Elsohly PhD., 5 Industrial Park Drive, Oxford,
Mississippi 38655, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the
basic classes of controlled substances listed in Schedule I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)............... I
Cocaine (9041)............................. II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Hydrocodone (9193)......................... II
Morphine (9300)............................ II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
for use in analysis and drug test standards.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Eli-Elsohly Laboratories, Inc. to manufacture the listed basic classes
of controlled substances is consistent with the public interest at this
time. DEA has investigated Eli-Elsohly Laboratories, Inc. to ensure
that the company's registration is consistent with the public interest.
The investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with
21 CFR 1301.33(a), the above named company is granted registration as a
bulk manufacturer of the basic classes of controlled substances listed.
Dated: May 2, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 05-9177 Filed 5-6-05; 8:45 am]
BILLING CODE 4410-09-P
